Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

10 Biggest Mid-Day Gainers For Wednesday

EXAS, EBIXQ, HMNY, INFIQ, X, CLRB

 

  • Helios and Matheson Analytics Inc (NASDAQ: HMNY) shares surged 33.08 percent to $13.16.
  • Aegerion Pharmaceuticals, Inc. (NASDAQ: AEGR) shares jumped 31.20 percent to $1.75 following merger announcement with QLT.
  • Infinity Pharmaceuticals Inc. (NASDAQ: INFI) rose 31.38 percent to $1.79. Morgan Stanley downgraded the rating on Infinity Pharmaceuticals from Overweight to Equal Weight, while lowering the price target from $11 to $1. Jefferies also downgraded the stock from Buy to Hold, while Wells Fargo downgraded the company from Outperform to Market Perform.
  • Patriot National Inc (NYSE: PN) shares surged 30.64 percent to $9.04 as Ebix Inc (NASDAQ: EBIX) offered to buy Patriot National for $9.50 per share.
  • Cellectar Biosciences Inc (NASDAQ: CLRB) shares gained 13.03 percent to $3.73 after the company reported positive results of a tumor-targeting study.
  • United States Steel Corporation (NYSE: X) shares climbed 9 percent to $17.81. Bank of America upgraded United States Steel from Underperform to Neutral and raised the price target from $10.00 to $18.00.
  • Rex Energy Corporation (NASDAQ: REXX) shares rose 7.52 percent to $0.863 as the company announced plans to sell Illinois Basin assets to Campbell Development for roughly $40 million – with the potential for up to an extra $10 million over the next three years, depending on commodity prices.
  • QLT Inc. (USA) (NASDAQ: QLTI) rose 6.99 percent to $1.53 following merger announcement with Aegerion Pharmaceuticals.
  • Denbury Resources Inc. (NYSE: DNR) gained 6.96 percent to $4.15. Analysts at Stifel Nicolaus upgraded Denbury Resources from Sell to Hold.
  • EXACT Sciences Corporation (NASDAQ: EXAS) rose 5 percent to $9.85 after surging 33.38 percent on Tuesday. BTIG maintained a Buy rating for the company, with a $9 price target. Canaccord raised price target for EXACT Sciences to $12.